Acacia latest life sciences play is about intangible assets - but not patents

Acacia latest life sciences play is about intangible assets - but not patents

Acquisition of stake in data-focused, medtech business, Sensyne is another sign of the NPE’s push to diversify its holdings

Unlock unlimited access to all IAM content